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In vitro formation and expansion of cysts derived from human renal
cortex epithelial cells. Acquired renal cysts derive from terminally
differentiated tubular epithelium in adults as a consequence of increased
epithelial cell proliferation, fluid accumulation and extracellular matrix
remodelling. To understand better how human epithelial cysts may be
initiated and progressively expand, cells from primary cultures of normal
human adult renal cortex were dispersed in polymerized type I collagen.
The transparent matrix permitted repeated observation by light micros-
copy of cyst formation from individual renal cells. The cyst cells reacted
strongly with distal nephron histochemical markers (cytokeratin antibod-
ies AE1/AE3, epithelial membrane antigen, and Arachis hypogaea lectin)
but inconsistently or not at all to markers of proximal tubules (Tet-
ragonolobus purpureas tectin and Phaseo/us vulgaris erthroagglutinin
lectin). The number of spherical, fluid-filled epithelial cysts that developed
in a standardized microscope field quantified cyst initiation. Cyst progres-
sion was determined from the increase in the diameter (surface area) of
cysts ancj represents a hyperplastic event. EUF or TGF,,, were required in
serum-free defined medium to cause cysts to develop from individual
epithelial cells dispersed in the matrix; insulin was required as a co-factor.
The EC50 for EGF was approximately 0.1 ng/nil, and for insulin I sgIml.
Early cultures of normal cortex formed cysts more efficiently when
dispersed in collagen matrix than cells passaged several times before
suspension in the gel. Agonists of adenylate cyclase (POE,, AVP, VIP,
PTH, forskolin, cholera toxin), methylisobutyixanthine, and 8-Br-cAMP,
though incapable of causing cyst formation alone in defined medium,
enhanced cyst initiation and progression in the presence of EGF and
insulin. Angiotensin II, TNF,,, /3-estradiol, and pertussis toxin had no
effect in the absence or presence of EOF and insulin. Pertussis toxin
inhibited cyst initiation and expansion caused by EGF and forskolin but
potentiated cyst initiation and expansion caused by EGF and POE1. Cyst
formation and expansion were inhibited by TGFI and 2-chloroadenosine.
Polarized monolayers of human renal cortical cells grown on permeable
membranes were used to independently quantify the effects of agonists on
the net secretion of solute and water from the basolateral to the apical
surface of the cells. POE,, forskolin, and 8-Br-cAMP stimulated net fluid
secretion that was sustained for several days; EGF enhanced forskolin.
stimulated fluid secretion. We conclude that the formation and expansion
of in vitro cysts derived from solitary human cortex cells depends on the
coordinated interplay between cellular proliferation and fluid secretion.
The initiation of cyst formation from solitary epithelial cells is determined
primarily by EGF or TGF, (cyclic AMP has a secondary role), whereas
the rate of fluid accumulation is controlled by cyclic AMP (EGF or TGF,,
have secondary roles). These experiments support the view that renal cyst
formation and growth may be regulated by endocrine, autocrine and
paracrine factors.
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Renal cysts may be acquired in individuals with no known
hereditary predisposition.' Acquired cysts are most commonly
solitary (25 to 50% of persons over 50 years of age), the
prevalence increasing as a function of age [1, 2]. Such cysts
appear to develop as miniature diverticuli of distal tubular
segments that occasionally enlarge to a diameter of several
centimeters 3]. They are typically filled with an electrolyte
solution similar in composition to an ultrafiltrate of plasma.
Acquired renal cysts in exaggerated numbers have been de-
scribed in subjects with progressive chronic renal disorders that
cause progressive loss of nephrons in the setting of a life
threatening decline in renal function [4]. In these cases, innu-
merable cysts develop in remnant nephrons possibly as a
consequence of forces that compensate for the loss of function-
ing renal tissue 5].
Three distinct factors have been identified as critical compo-
nents in the pathogenesis of all types of renal cysts 6]. First,
there is proliferation of cells in the parent renal tubule that leads
to expansion of the segment. Whether the increase in cell
proliferation is clonal, or initiates in one or several cells in a
given segment has not been determined. Second, there is
accumulation of fluid within the nascent cyst. In the earliest
stages the fluid derives from glomerular filtrate, but as the cysts
expand they may dislodge from the parent nephron, in which
case filling is exclusively by transepithelial secretion. Third,
there are extensive changes in the tubule basement membrane
and extracellular matrix adjacent to cysts that may have pri-
mary or secondary roles in the formation and enlargement of
these structures.
Although little is known about the specific mechanisms that
stimulate cyst formation in intact renal tubules, recent studies
utilizing in vitro methods have uncovered some of the factors
that may initiate cyst formation by renal epithelial cells and
Abbreviations are: EGF, epidermal growth factor; TGF,,, trans-
forming growth factor alpha; TGFI, transforming growth factor beta;
PDGF, platelet derived growth factor; basic FGF, basic fibroblast
growth factor; TNF, tumor necrosis factor alpha; ANP, atrial natri-
uretic peptide; AVP, arginine vasopressin; PGE,, prostaglandin El;
MIX, methylisobutylxanthine; TP, Tetragonolohus purpureas lectin;
PHA-E, Phaseolus vulgaris erythroagglutinin lectin; AH, Arachis hy-
pogaea lectin; EMA, epithelial membrane antigen; AEI/AE3, antibod-
ies to cytokeratin; THP, Tamm-Horsfall protein.
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Fig. 1. Development in polymerized Type I collagen matrix of cysts derived from human renal cortex cells. Source of cells was a subconfluent
primary culture of human kidney cortex. A. Appearance of cells suspended in matrix and administered basal medium for 13 days. B. Treatment
of cells with PGE1 (70 nM) and MIX (100 M) for 13 days. C. Treatment of cells with EGF (25 ng/ml) for 13 days. D. Treatment of cells with EGF
(25 ng/ml) and forskolin (10 sM) for 13 days. All photos taken at same original magnification. Largest cyst diameter in panel D is 617 sm.
promote progressive enlargement of established cysts. Madin-
Darby canine-kidney (MDCK) cells, an established line derived
from distal nephron, form spherical, monolayered, fluid-filled
cysts when they are cultured in a matrix of polymerized type I
collagen [7, 8]. The proportion of single cells that form cysts
and the rate at which cysts expand can be increased by
stimulating the production of intracellular cyclic AMP, which
increases the rate of cell proliferation and the rate of transepi-
thelial fluid secretion into the cysts [9].
Cells derived from primary cultures of human renal cortex
also develop cysts when they are cultured in Type I collagen
matrix in a medium supplemented with fetal bovine serum [10].
Baby mouse kidney cells form rudimentary tubular structures in
a matrix of reconstituted basement membrane when they are
treated with EGF or TGF [11]. Thus, morphologically differ-
entiated structures recognized as epithelial cysts or tubules may
emerge in vitro from solitary cells derived from: (I) an immortal
line, or (2) primary cultures of terminally differentiated cells. In
the present study, we utilized primary cultures of human renal
cortex cells in a systematic search for modulators of two stages
of the in vitro cystogenic process: initiation, which renders the
cells competent to form cysts in a collagen matrix, and progres-
sion, which promotes the enlargement of established cysts
through increased cell proliferation and fluid secretion.
Methods
Primary cultures of human kidney cortex
Cortex of kidneys from four individuals was available for
study; two of the kidneys had been retrieved from cadavers and
were anatomically unsuitable for renal transplantation and the
other two kidneys were surgically removed for localized ade-
nocarcinoma (the normal portions were used for culture). Renal
cortex from each kidney was minced, incubated in unsupple-
mented DMEIFI2 medium containing collagenase (I mg/mI,
Cooper Biochemicals, Malvern, Pennsylvania, USA), penicillin
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Fig. 3. The effect of duration in culture on the initiation of cysts by
EGF. Source of cells was a frozen subeonfluent primary culture of
human renal cortex cells. Cells were grown on plastic dishes for 2, 3, 7
and 12 days before they were imbedded in collagen matrix and treated
with EGF (2.5 ng/ml) for an additional 13 days. Subconfluent cultures
covered less than 50% of surface area. Confluent cultures showed no
uncovered surface by direct observation. Passage in this experiment is
defined as subculture (1:4) onto a plastic dish beyond the initial plating
of the frozen cells derived from a subconfluent primary culture. Each
bar represents mean data from 10 microscope fields. Horizontal lines
SEM.
DMSO in DME/F12 containing 5% FBS, insulin, transferrin,
selenium, penicillin and streptomycin. The tubes containing Ito
2 million cells in one ml of medium were placed in a —20°C
freezer until frozen solid, and then were transferred to a —90°C
freezer. The cells were rapidly thawed in a 35 to 37°C water
bath and transferred to a T flask containing medium prewarmed
to 37°C. Freezing had no apparent effect on the subsequent
growth behavior of cells on plastic, in collagen gel or on
Transwells in comparison to primary cultures of the same cells.
In vitro formation in polymerized collagen matrix
EGF, ng/m/
Fig. 2. Concentration-dependence of cyst formation on EGF. Source
ofcells was a subconfluent primary culture of human kidney cortex. A.
Effect of EGF (•) and EGF + forskolin (E, 10 M) for 13 days on the
initiation of cyst formation as reflected by the average number of cysts
in each of 10 microscope fields. B. Effect of EGF and EGF + forskolin
(same preparation as panel A) on the progression of cyst expansion as
reflected by the average combined cyst surface area in 10 microscope
fields. Vertical lines SEM.
G (100 U/mI) and streptomycin (0.1 mg/mI) for sufficient time
(usually several hours) to cause dispersion of individual tubular
fragments, The tubule-rich pellet was rinsed in DME/F12 and
plated onto T-75 flasks in medium containing DME/F12, 5%
FBS, 10 ng/ml EGF, 5 g/ml insulin, 5 g/ml transferrin, 5
ng/ml sodium selenite, penicillin and streptomycin.
Cells were grown at 37°C in 5% C02/air. After 24 hours, loose
cells and debris were decanted. Attached cells and small tissue
pieces were the sites of cell outgrowths that eventually became
confluent. In preliminary studies, the primary cultures were
passaged at various times before confluency was reached in
order to determine if low generation number enhanced the
efficiency of cyst formation in collagen matrix. Samples were
either taken directly for study or were frozen at —90°C in 10%
We used a method reported previously from this laboratory
181. Briefly, the cultures were released from the plastic dishes
with trypsin. After removal of trypsin, cells were dispersed in
ice-cold Type I collagen (Vitrogen, Collagen Corp, Palo Alto,
California, USA) at pH 7.4, and 0.4 ml (10,000 cells) were
deposited in specific wells of a 24-well culture plate. After
polymerization, 1.5 ml of DME/Fl2 medium containing 5 g/ml
insulin, 5 g/ml transferrin, 5 ng/ml sodium selenite, 5 x IO M
hydrocortisone, 5 x l0 M triiodothyronine, 100 U/mI peni-
cillin and 0.1 mg/mI streptomycin was added above the gelled
matrix, unless stated otherwise. The plates were kept in a
Queue CO2 incubator (Queue, Parkersburg, West Virginia,
USA) in an atmosphere of 5% CO2 in room air at 37°C. Medium
was replaced three times each week and the cells were in-
spected by light microscopy at periodic intervals. Experience
showed that in medium supplemented with in vitro cystogens
(EGF and TGF) cyst initiation and growth of sufficient mag-
nitude for quantitative study was adequate after 13 days of
incubation.
The experiment was terminated by the addition to each well
of one ml of 2% formaldehyde or glutaraldehyde in isosmotic
phosphate-buffer which fixed the cysts for an indefinite period
without anatomic distortion or change in size. The diameter of
each well was 1.55 cm (area = 1.89 cm2). To quantify cyst
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Fig. 4. EGF requirement for continuous cyst
formation and expansion. Source of cells was
a frozen subconfiuent primary culture of
human kidney cortex cells. Cells embedded in
collagen I were treated with a fixed
combination of EGF (2.5 nglml) and/or
forskolin (10 zM) for up to 13 days, or with
EGF or forskolin for variable periods. EGF
had to be present continuously from Day 0 to
initiate a maximal number of cysts in the 13
day duration of study. Forskotin potentiated
cyst initiation, but was insufficient alone to
cause cyst formation or to maintain cyst
growth that had been initiated by the pulse
treatment of cells with EGF. Days of
treatment refers to the duration each
constituent was present beyond the starting
point, Day 0. Each bar represents mean data
from 10 microscope fields. Horizontal lines
SEM.
initiation, each well was divided into five continuous micro-
scope fields, each covering —0. 126 cm2 (total area/well —0.63
cm2). A total of 10 fields in two wells (33.3% of total area of the
two wells) were examined for each experimental condition.
Cysts were defined as spheroids (a geometrical shape readily
determined by varying the depth of focus) with transparent
cavities, distinct cellular linings, and outer diameters exceeding
80 xm. The size limit insured that small cellular clumps or loose
aggregates were not counted as cysts during quantitation at low
power magnification (lOOx). Inspection of the gels at high
magnification (400x) confirmed that the number of cysts per
field, determined with the low power objective, was a valid
reflection of the total number cysts (larger and smaller than the
80 tm diameter limit) that had formed in each experimental
condition. Outer diameter of each cyst was determined with an
eyepiece micrometer from the average of two measurements at
right angles. Average surface area (r D2) was determined from
the combined surface area of cysts in each of 10 fields. In a
previous study, the surface area of individual cells was the same
in relatively small and large MDCK cysts [8]; thus, mean
surface area was held to reflect cell number, and was used as a
relative index of cell proliferation rate.
Measurement of fluid secretion rate
The method for measuring fluid secretion rate across polar-
ized epithelial monolayers has been described in detail [121. The
source of cells was frozen subconfluent primary cultures. These
cells were grown in plastic dishes in DME/Fl2 medium supple-
mented with 5% FBS, insulin, transferrin, selenium, penicillin
and streptomycin. One million cells, seeded onto the upper
surface of 24.5 mm diameter Transwell-CoI (Costar Corp.,
Cambridge, Massachusetts, USA) culture chamber inserts
coated with Type I and Type III collagen, developed confluent
monolayers in one to two days and were adapted another three
to four days before study. Experience showed that 5% FBS in
the basolateral medium was necessary for the cellular mono-
layer to remain attached to the supporting membrane; this
concentration of FBS also supported optimal fluid secretion. To
begin the study, the upper chamber fluid was completely
replaced with mineral oil (1.5 ml); the outer bath contained 1.5
ml of culture medium, a volume that assured that the level of
fluid in the inner chamber above the cell layer was always
higher than that of the bath. With this arrangement, fluid could
move passively in response to hydrostatic gradients only from
apical to basolateral media; movement of fluid from outer to
inner chamber compartment required active transport by the
cellular layer.
Transmission electron micrographs of glutaraldehyde-fixed
specimens showed that the apical surfaces of the cells faced the
inner chamber and the basolateral surface was apposed to the
permeable membrane and thereby exposed to fluid in the outer
chamber. DME/F12 containing 5% FBS, insulin, selenium,
transferrin and penicillin was placed in the outer chamber and
test agents were added individually to this medium. Every 24
hours the oil/fluid layer in the apical (inner) compartment was
collected by aspiration and the volume of water determined as
described previously [9, 10, 12, 13]. Net fluid secretion rate was
equal to the volume of fluid collected divided by the surface
area of the chamber (4.71 cm2) and the duration of the experi-
mental period (24 to 72 hr).
His tochemical examination of polarized monolayers and
embedded cysts
For these studies, cultured cells grown on Transwells or in
collagen matrices were fixed in 10% buffered formalin for four
to six hours and stored in 70% ethanol until processed. Cells
were dehydrated through graded ethanol (70, 95, 100%) and
xylene and embedded in paraffin. Sections were cut at five
micron intervals on a Reichert 2040 microtome and placed on
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Fig. 5. Effect of insulin on EGF-induced cyst initiation and progressive
enlargement. Source of cells was a frozen subconfluent primary culture
of human kidney cortex cells. Cells imbedded in collagen matrix were
treated with different concentrations of insulin for 13 days. A. The
initiation of cyst formation as reflected by the average cysts/field. B.
The progressive enlargement of the same population of cysts shown in
A as reflected by the average surface area/field. EGF concentration was
2.5 ng/ml throughout. Each bar represents mean data from 10 micro-
scope fields. Vertical lines SEM.
silanized glass slides, dried and treated at 60°C for 60 minutes.
Sections were stained with hematoxylin and eosin and various
tubular differentiation markers as described in detail previously
[14—181. Proximal tubule markers were: peroxidase labeled
Tetragonolobus purpureas (TP) lectin (Sigma, St. Louis, Mis-
souri, USA) and biotinylated Phaseolus vulgaris erythroagglu-
tinin (PHA-E) lectin (Vector Labs, Burlingame, California,
USA). Distal nephron (distal convoluted tubule, collecting
duct) markers were: peroxidase labeled Arachis hypogaea (AH)
lectin (Sigma), as well as unlabeled antibodies against epithelial
membrane antigen (EMA) (DAKO Corp., Santa Barbara, Cal-
ifornia, USA) and AE1IAE3, a mixture of monoclonal antibod-
ies against high molecular weight cytokeratins that are not
present in proximal tubular epithelial cells (Hybritech Inc.. San
Diego, California, USA). An antibody against Tamm-Horsfall
protein (THP) (courtesy of Dr. John Hoyer, Children's Hospital
of Philadelphia, Pennsylvania, USA) was used as marker of
thick ascending loop of Henle and possibly the proximal part of
the distal convoluted tubule. The procedure of Faraggiani and
coworkers [19] was used for AH and TP with the following
minor modifications: (I) phosphate buffered saline (PBS) (0.02
M) was used as the buffer; (2) 0.5% hydrogen peroxide in
methanol was used for quenching endogenous peroxidase ac-
tivity; (3) incubation time with the lectins was increased to one
hour. Briefly, deparaffinized sections were treated with 0.5%
hydrogen peroxide in methanol for 30 minutes and placed in
0.02 M PBS. The sections were incubated with each lectin for 60
minutes at room temperature. The concentration of AH and TP
was 0.01 mg/mI and 0.03 mg/mI, respectively. Sections were
washed twice for five minutes in PBS followed by 3-amino-9-
ethylcarbazole (AEC) (BioGenex Labs., San Ramon, Califor-
nia, USA). The development of the color reaction was moni-
tored under the microscope. When the color reaction became
optimal, slides were rinsed in distilled water for five minutes
and counterstained with Meyer's hematoxylin for two minutes.
Slides were then dipped several times in tap water, followed by
distilled water and mounted (Biomeda, Foster City, California,
USA). The procedure for PHA-E was the same except that after
the PBS wash a prediluted avidin-biotin peroxidase complex
(ABC) (Lipshaw, Detroit, Michigan, USA) was applied for 30
minutes at room temperature followed by a PBS wash and
AEC. The concentration of PHA-E was 0.001 mg/mI.
A peroxidase-anti-peroxidase method was used for antibody
markers [201. Briefly, sections were deparaffinized, treated with
0.5% H202 in methanol and washed in PBS. Normal rabbit
serum diluted 1:20 was applied for 20 minutes prior to the
incubation with the primary antibodies for one hour at room
temperature. The antibodies against EMA and cytokeratin
(AE1/AE3) were used at a dilution of 1:20 and 1:100, respec-
tively. Slides were incubated with a rabbit anti-mouse second-
ary antibody (DAKO) at a 1:50 dilution for 20 minutes at room
temperature followed by the application of mouse PAP complex
(DAKO) diluted to 1:100, also for 20 minutes. Sections were
washed twice in PBS after each incubation. The same basic
procedure was used for the polyclonal THP antibody. Sections
were incubated with normal swine serum 1:20, followed by the
rabbit anti-THP antibody overnight at 4°C at a dilution of 1:200.
The secondary antibody was swine anti-rabbit (DAKO) diluted
1:50, followed by the rabbit PAP complex at a 1:100 dilution for
20 minutes. The chromogen, the counterstain and the mounting
media were the same as for the lectin studies.
Positive controls were paraffin sections of normal human
kidneys to verify that the lectins and antibodies were staining
the correct segment of the nephron. Negative control for the
peroxidase-labelled lectins was omission of the lectin with
application of the chromogen only. Negative control for PHA-E
was the omission of the lectin and the application of the reagent
with the chromogen. Negative controls for monoclonal antibod-
ies and the polyclonal antibody were: (I) replacement of the
primary antibody with a hybridoma:derived mouse monoclonal
IgGI standard (Bethyl Labs Inc., Montgomery, Texas, USA) or
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Fig. 6. Effect of medium constituents on cyst
initiation and progressive enlargement.
Source of cells was a frozen subconfiuent
primary culture of human kidney cortex cells.
Cells imbedded in collagen matrix were
treated for 13 days with constituents added to
defined medium (DME/F12) containing ITS
[insulin (5 tg/ml), transferrin (5 gIml), and
sodium selenite (5 nglml)]. Tri-iodothyronine
(5 x 1012 M) and hydrocortisone (5 x 108
M), added independently or together to the
defined medium did not cause cysts to form
(data not shown). A. Triiodothyronine and
hydrocortisone enhanced the effect of EGF
(2.5 nglml) to initiate cyst formation.
Forskolin (10 M) and PGEI (71 nM) further
enhanced cyst initiation. B. Triiodothyronine
and hydrocortisone enhanced the effect of
EGF to promote cyst expansion. Forskolin
and PGEI further enhanced cyst expansion.
Each bar represents mean data from 10
microscope fields. Horizontal lines SEM.
normal rabbit serum respectively, at the same concentration as
the primary antibodies; (2) omission of the primary antibody.
Media and chemicals
DME/F12 was from Hazelton Biologicals, Lenexa, Kansas,
USA. From Sigma we purchased EGF (receptor grade), PDGF,
basic FGF, 2-chioroadenosine, ANP(3-28), AVP, PTH, VIP,
PGE1, forskolin, cholera toxin, 8-Br-cAMP, pertussis toxin,
/3-estradiol and angiotensin II. TGF was from Collaborative
Research (Bedford, Massachusetts, USA). From Research and
Diagnostics Systems (Minneapolis, Minnesota, USA) we pur-
chased TGFI and TNF. Normal human serum was obtained
from the authors and uremic human serum was obtained from
hemodialysis patients after informed consent.
Results
Cultures of human renal cortex cells
Primary cultures of renal cortex cells from each of the four
kidneys grew to confluent monolayers on plastic dishes in four
to six days when incubated in DME/Fl2 medium supplemented
with 5% FBS, insulin, transferrin and selenium. For the studies
described in this report, we used cells directly from subconflu-
ent primary cultures of human renal cortex and cells from
subconfluent primary cultures that had been frozen. Cells from
either source grew well on plastic and on polarized permeable
supporting membranes coated with types I and III collagen
(Transwell-Col). After the fourth passage (1:4), the cells usually
became senescent.
Initiation of cyst formation in collagen matrix
Subconfluent cultures grown in plastic dishes or collagen-
coated permeable membranes were freed with trypsin and
dispersed within ice-cold liquid collagen. After gelation, the
suspended cells were incubated in medium containing potential
in vitro cystogens and observed daily for up to four weeks. No
cysts formed in response to defined medium containing insulin
(5 ig/ml), sodium selenite (5 ng/ml), transferrin (5 sg/ml),
triiodothyronine (5 x 10— 12 M) and hydrocortisone (5 x i0_
M). Fetal bovine serum (FBS 5 to 10%) added to medium caused
a few cysts to form in only 2 of 10 separate experiments. By
contrast, addition of EGF routinely initiated cyst formation in
collagen matrix of cells from four different adult human kidneys
(Figs. 1, 2). The results reported here were derived primarily
from the kidneys of two males.
The yield of cysts in medium containing EGF was inversely
related to the length of time the primary cultures were grown on
plastic dishes before embedding the cells in collagen matrix
(Fig. 3). We limited studies, therefore, to cells obtained from
the initial culture or the first passage.
The mean EC50 for EGF-mediated cyst formation in two
studies was approximately 0.1 nglml (one experiment is illus-
trated in Fig. 2). Pulse treatment with EGF of cells suspended
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Table 1. In vitro cystogenic effect of potential agonists in relation
to EGF
Cysts/field Surface area
relative to relative to
Replacement EGF + EGF +
for EGF Concentration insulina insulin
TGF,, 25 ng/ml 1.33 0.10 1.66 0.21
Insulin 5 tg/ml nil nil
Fetal bovine 0.5% nil nil
serum
Fetal bovine 5.0% nil nil
serum
Normal human 5.0% nil nil
serum
Uremic human 5.0% nil nil
serum
PDGF 3 ng/ml nil nil
TGFn1 2 ag/mI nil nil
TNF,, 0.1 ng/ml nil nil
FGF 20 ng/ml nil nil
Angiotensin II 0.1 /SM nil nil
PGE1 70 n nil nil
PTH 100 nM nil nil
Pertussis toxin 0.5 sg/ml nil nil
Forskolin 10 M nil nil
MIX 1 m nil nil
8-Br-cAMP I m nil nil
Atrial natriuretic 0.1 sM nil nil
peptide
Beta estradiol 25 ng/ml nil nil
EGF 2.5 ng/ml and insulin 5 g/ml
in matrix led to reduced numbers of cysts (Fig. 4); thus, EGF
had to be continuously present in the medium to permit the
formation of an optimum number of cysts. This suggests that
cyst initiation continued for several days after seeding the cells
in the gelled matrix.
We determined the extent to which several substances com-
monly added to defined media potentiated the EGF-induced in
vitro formation of cysts (Fig. 5). Insulin proved to be essential
for cyst formation as EGF or insulin alone was inadequate to
form cysts. The EC50 for insulin was approximately I g/ml,
which is within the physiologic range of human plasma insulin
levels. Hydrocortisone and triiodothyronine (with insulin,
transferrin and selenium in the medium), independently or in
combination, did not cause cysts to form in the absence of
EGF. On the other hand, hydrocortisone and triiodothyronine
enhanced the formation of cysts in response to EGF and insulin
(Fig. 6).
TGF, also caused cysts to form in collagen gel; however,
PDGF, basic FGF, normal human serum, uremic human serum,
TNF,, TGF0, 2-chloroadenosine, atrial natriuretic peptide,
AVP, PTH, VIP, PGEI, forskolin, cholera toxin, 8-Br-cAMP,
pertussis toxin, beta estradiol and angiotensin II were not
uniquely cystogenic (Table 1).
Modulators of cyst initiation and enlargement in collagen
matrix
To determine the extent to which growth factors and other
substances might stimulate or inhibit cytogenesis, we examined
the effect of specific agents in combination with EGF and
insulin. Receptor-mediated agonists of the cyclic AMP pathway
(PGE1, AVP, PTH, VIP, and isoproterenol) enhanced the
initiation and progressive enlargement of cysts (Fig. 7). Forsko-
lin, which directly stimulates adenylate cyclase, cholera toxin,
which stabilizes GTP-binding stimulatory proteins, MIX, which
inhibits phosphodiesterase and 8-Br-cAMP, a congener of the
active nucleotide, potentiated the initiation and expansion of
cysts (Fig. 7).
ANP action is mediated through cyclic GMP in several
tissues including kidney. This peptide increased cyst initiation
and expansion (Fig. 7). Angiotensin II and /3-estradiol had no
effect on cyst initiation and expansion.
Pertussis toxin alone had no effect on cyst initiation in the
absence of EGF and forskolin (Table 1). Pertussis toxin reduced
cyst initiation and progressive cyst enlargement caused by EGF
and forskolin (Fig. 8). By contrast, pertussis toxin potentiated
cyst initiation and progression caused by EGF and PGE1.
Pertussis toxin did not alter the effect of 8-Br-cAMP to stimu-
late cyst initiation and enlargement. Although not included in
the experiment illustrated in Figure 8, in a separate study
pertussis toxin (0.5 tg/ml) did not significantly decrease cyst
initiation (EGF [cysts/field] 2.60 0.45, EGF + pertussis toxin
2.00 0.52) or progressive enlargement (EGF [surface area x
IO cm2] 2.02 0.39, EGF + pertussis toxin 1.14 0.38)
caused by EUF.
TGFI alone had no effect on cyst initiation and progressive
enlargement (Table 1); however, the peptide inhibited the effect
of EGF on cyst initiation and enlargement (Fig. 9). The maxi-
mally effective concentration of TGF0I (5 ng/ml) completely
blocked cyst formation by EGF. Forskolin stimulation ap-
peared to preserve the stimulatory action of EGF in response to
submaximal concentrations of TGFI. and 0,05 ng/ml may have
potentiated the effect of EGF on cyst initiation and progression
(Fig. 9).
2-Chloroadenosine, a non-inetabolizable congener of adeno-
sine, inhibited cyst initiation and enlargement caused by EGF
(Fig. 10). Complete inhibition of the EGF effect was observed at
a 2-chloroadenosine concentration of 100 t; the half-maximal
concentration was approximately I LM. The highest concentra-
tion of 2-chloroadenosine (100 M) also blocked the combined
effect of EGF and forskolin; however, the lower concentrations
of 1 sM and 1 nM were without effect,
Fluid secretion by polarized monolayers of human renal
cortex cells
Previous studies had shown that PGE,, forskolin and 8-Br-
cAMP stimulated the net secretion of fluid by monolayers of
human renal cortex cells 110]. We confirmed those findings in
the current study and showed further that arginine vasopressin
also increased the secretion of fluid by monolayers (Fig. 11).
The effects of the cyclic AMP agonists were sustained for at
least three days and were reversed on removal of the drugs.
Cholera toxin also stimulated fluid secretion (data not shown).
EGF alone had no effect on fluid secretion by monolayers of
human renal cortex cells; however, the growth factor increased
the secretion rate caused by forskolin (Fig. 12). The effect of
EGF on forskolin-mediated fluid secretion was reversible. The
effect of EGF to potentiate forskolin-stimulated fluid secretion
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was not due to an increase in cell number as the number of cells
was not different between EGF-treated and untreated Tran-
swells at the conclusion of the experiment (data not shown).
Epithelial origin ofcultured human cortex cells
Standard light microscopy and transmission electron micros-
copy of fixed specimens of embedded cysts and monolayers on
Transwell membranes showed features of epithelial cells (data
not shown). Apical microvilli and apical intercellular junctional
complexes were indicative of orthodox cellular polarity, but no
other distinguishing morphologic characterics of well-differen-
tiated renal tubule epithelial cells were noted.
Histochemical analysis of kidney cells from two individuals
indicated that the cysts and the monolayers were derived from
distal tubular elements, primarily. Cysts and monolayers re-
acted strongly with antibody to AE l/AE3 and to a lesser degree
with antibody to EMA, both of which are markers of distal
segments (Fig. 13, Table 2). The distal lectin, AH, also reacted
focally with embedded cysts and the monolayers stained pri-
marily along the apical surface membranes. Tamm-Horsfall
protein, associated with thick ascending limbs, showed weak to
moderate reaction with embedded cysts and monolayers (Table
2). Reaction with the proximal tubule marker PHA-E was, at
best, weak and focal, and there was no staining with the
proximal tubule marker TP. MDCK cells are thought to derive
Fig. 7. Effect of cyclic AMP and other
agonists on EGF-induced cyst initiation and
enlargement. Source of cells was a frozen
subconfiuent primary culture of human kidney
cortex cells. Cells were treated with EGF (2.5
ng/ml) plus additional agonists for 13 days.
Results of individual agonists were related to
the mean number of cysts/field (A) or the
average total surface area per field (B) for
EGF alone. EGF was included as a
contemporary reference in all studies; mean
absolute cysts/field for six different
preparations was 3.77 0.99 (sEM); mean
absolute surface area for five different
preparations was 4.27 1.56 (5EM) X 1O
cm2. Each bar represents the mean SEM of
data from 10 microscope fields. Levels of
significant difference from the EGF control
(1.00 in both A and B) determined by one-way
ANOVA and Fisher's test were * <0.05.
from distal tubule segments; monolayers of MDCK handled in
the same fashion as human renal cortex cells reacted strongly
with AEI/AE3 and moderately with THP. There was no reac-
tion with the proximal markers TP and PHA-E.
Discussion
Current studies confirm that cells released enzymatically
from terminally differentiated adult human kidney tubules can
proliferate and organize in vitro into structures that exhibit
certain morphological and functional properties of difl'erenti-
ated renal epithelium. The cysts that develop in polymerized
Type I collagen in the presence of EGF and other promoters of
proliferation and fluid secretion may represent a type of aber-
rant tubulogenesis in which the proliferating cells, lacking the
organized tubular framework of the basement membrane to
guide development, initially form small nodules. Epithelial cells
attached by junctional complexes to one another in the nodule
and stimulated to transport solutes and water from cell base to
apex (secretion) form cysts, since in the absence of an orga-
nized scaffold, the contiguous cells are probably more likely to
form a geometrically stable sphere than an elongated tubule.
Previous work from this and other laboratories revealed that
not all types of renal cells would form in synthetic matrices
cysts with orthodox polarity. McAteer, Evan and Gardner [7],
Wang, Ojakian and Nelson [21, 22], and Grantham (unpublished
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Fig. 8. Effect of pertussis toxin on cyst
initiation and progressive enlargement.
Source of cells was a frozen subconfluent
primary culture of human kidney cortex cells.
Embedded cells were studied for 13 days.
Pertussis toxin (PT) alone (0.5 pg/mI) had no
effect, but in combination with EUF (2.5 ng/
ml) or EGF forskolin (10 jsM), pertussis
toxin decreased the initiation and progressive
enlargement of cysts potentiated by forskolin
(8 P C 0.001), increased the initiation and
progressive enlargement potentiated by PGE1(# P < 0.001) and had no effect on initiation
and progressive enlargement potentiated by
8-Br-cAMP. Each bar represents mean 5EM
data for 10 microscope fields.
Table 2. Histochemical studies of cyst forming epithelial cells
Cell
type_______ Preparation
TP PlIA-E
________
Proximal
fliP
(TALH)
AEI/AE3
.
AH EMA
Distal
1+ focal apical 08MDCK monolayer 0 0 2+ 4+
HRC I monolayer 0 I + focal 0 3+-4+ 2+ focal apical 4+
HRC 2 monolayer 0 1+ focal 1+ 1+ 2+ focal apical 3+
HRC 3 cysts/matrix ND 1+ 2+ 4+ focal 1+12+ focal apical 1+/3+
Sources of cells were a frozen subconfluent primary culture of a single human kidney and a subculture of MDCK cells 9]. Monolayers were
grown to confluence on Transwell-col membranes; cysts/matrix indicates that spherical cysts were grown within polymerized collagen matrix.
MDCK, Madin-Darby canine kidney; HRC, human renal cortex cells (1, 2, 3 represent different preparations of the same HRC primary culture.
Intensity of reaction was qualitatively graded 0 nil; 1+ = definite but indistinct; 2+ = weakly reactive in some cells; 3+ moderately reactive
in most cells; 4+ = strongly reactive in most cells. ND = not done.
Fixed sections of normal human kidneys gave 4+ reactions in the specific tubule segments (proximal, thick ascending loop of Henle, distal
convulted/collecting duct) for the appropriate histochemical markers.
observations) found that MDCK cells formed monolayered
epithelial cysts in Type I collagen matrix, but in a matrix of
gelled agarose or in suspension culture the orientation of the
cyst forming cells was reversed, with cell apex exposed to the
outer medium and the basolateral surface facing the cavity side.
These simple experiments provide compelling evidence that
qualities of the matrix are determinants of cell orientation in
cyst walls in vitro.
LLC-PKI cells, derived from porcine proximal tubules, form
domes when cultured in plastic dishes and absorb fluid when
cultured on permeable supports (J.J. Grantham and M. Grant,
unpublished observations). Cells subcultured from MDCK
cysts that formed in an agarose matrix also form domes when
cultured on plastic dishes and absorb fluid when cultured on
permeable supports (J.J. Grantham and M. Grant, unpublished
observations). Dome-forming MDCK cells may not form cysts
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Fig. 9. Effect of TGF, on cyst initiation and
progressive enlargement. Source of cells was
a frozen subconfluent primary culture of
human kidney cortex cells. Embedded cells
were studied for 13 days. TGFI alone (5 ngl
ml) had no effect, but in combination with
EGF (2.5 nglml) or EGF + forskolin (10 jM),
TGF01 inhibited cyst initiation (A) and
progressive enlargement (B) caused by EGF
alone (* P < 0.001) and EGF combined with
forskolin (# P < 0.001). The lowest
concentration of TGFaI (0.05 ng/ml) enhanced
cyst enlargement. Each bar represents mean
data SEM for 10 microscope fields.
Fig. 10. Effect of 2-chioroadenosine on cyst
initiation and progressive enlargement.
Source of cells was a frozen subconfiuent
primary culture of human kidney cortex cells.
Embedded cells were studied for 13 days. 2-
Chloroadenosine alone (1 M) had no effect,
but in combination with EGF (2.5 ng/ml) or
EGF + forskolin (10 ILM), 2-chloroadenosine
inhibited cyst initiation (A) and progressive
enlargement (B) caused by EGF alone (* P <
0.001) and EGF in combination with forskolin
(# P < 0.001). Each bar represents mean data
SEM for 10 microscope fields.
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Fig. 11. Stimulation of net fluid secretion by
polarized epith c/ia! mono/ayers derived from
human renal cortex cells. Source of cells was
a frozen subconfluent primary culture of
human kidney cortex cells. Confluent
monolayers were treated after adaptation on
Transwelt-col supports (control period) with
forskolin (U, 10 /M), PGE1 (D, 70 nst), 8-Br-
cAMP (, 1 msi) or AVP (l1, 10 mU/mi) in
the basolateral medium. After three days, the
agonists were removed. Vertical bars indicate
mean data from triplicate determinations
sEM. All agonists significantly stimulated net
fluid secretion above baseline (P < 0.01).
0 Control 1 2 3 Control Control
medium medium medium
Days after
adding agonist
Fig. 12. Effect of EGF on fluid secretion by polarized epithelial mono-
layers. Source of cells was a frozen subconfluent primary culture of
human kidney cortex cells. Confluent monolayers were adapted on
Transwell-col supports (control period). EGF (—0—--, 2.5 ng/ml), for-
skolin (—U-—, 10 sM) or EGF + forskolin (—A----) were added to the
basolateral medium. After three days the agents were removed and two
24-hour control measurements were made. Each symbol represents the
mean of triplicate determinations sEM (the SEM values are enclosed
by the symbols in most cases). Forskolin significantly stimulated fluid
secretion above baseline (P < 0.001) and EGF, which had no effect
alone, enhanced the effect of forskolin (P < 0.01).
in Type I collagen matrix [101 because absorptive net fluid
transport precludes development of a cavity adjacent to the
apical surfaces of the cells. Although we have not tested an
extensive array of renal epithelial cells, it seems self evident
that cyst formation in collagen matrix in vitro by cells derived
from renal epithelium will depend on at least three critical
factors: (1) proliferation of the epithelial cells; (2) cell polarity,
that is, the respective orientation of the classical apical and
basolateral transporters; and (3) linkage between epithelial
polarity and net solute transport in a way to promote fluid
secretion into the cavity.
The cells in the current study were obtained from renal
cortex. One would suppose that proximal tubule cells would
predominate in the primary cultures; however, the methods
used in these studies apparently selected cells of distal nephron
phenotype since cysts embedded in Type I collagen matrix and
monolayers cultured on permeable membranes coated with
Type I and Type III collagen reacted diffusely, regularly and
strongly only with histochemical markers that identify distal
nephron segments. The response of collagen-embedded human
renal cortex cells to potential agonists of cystogensis was also
consistent with the response anticipated of distal nephron
segments. Prostaglandin E1, vasopressin, parathyroid hor-
mone, vasoactive intestinal polypeptide and isoproterenol [23—
25] are known to activate adenylate cyclase in distal nephron
segments of mammalian kidneys, and these agonists increased
the initiation and enlargement of human renal cortex cysts
treated with EGF (Fig. 7). Cholera toxin, forskolin, methyl-
isobutylxanthine and 8-Br-cAMP, which are known to stimulate
or mimic increased levels of intracellular cAMP, also increased
the initiation and enlargement of human renal cortex cysts. It
seems reasonable to conclude from these observations that
cysts derived from human renal cortex cells possess receptors
for PGE1, AVP, PTH, VIP and isoproterenoi together with the
intracellular components necessary for functional expression of
an intact adenylate cyclase signal transduction system.
Pertussis toxin, which had no effect alone or in combination
with EGF, inhibited the cystogenic response to EGF and
forskolin and stimulated the combined effect of EGF and PGE1.
Pertussis toxin had no effect on the response to EGF and
8-Br-cAMP, suggesting that modulation of cyst initiation and
enlargement by the toxin was localized to adenylate cyclase or
E
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processes proximal to the enzyme. Guanine-dependent inhibi-
tory proteins may eventually prove to have roles in cystogen-
esis that are as complex as those observed in other hormone-
mediated processes i renal tubules [261.
The survey of potential agonists and inhibitors of cystogen-
esis was extended outside the cyclic AMP signal transduction
pathway. Relatively high concentrations (10—v NI) of atrial
natriuretic peptide stimulated cyst initiation and progressive
enlargement. This hormone promotes diminished salt and water
reabsorption by medullary collecting ducts by increasing intra-
cellular levels of cyclic GMP [261. Preliminary studies in our
laboratory suggest that cyclic GMP may also promote fluid
secretion across monolayers of human renal cortex cells (J.J.
Grantham, unpublished observations). Angiotensin II, which
stimulates fluid reabsorption and promotes hypertrophy of
proximal tubule cells [27, 281 had no effect in human renal
cortex cells embedded in collagen matrix. p-Estradiol, repre-
senting a unique class of steroid hormones, had no effect on
cystogenesis. TGF01, which alone had no effect on cystogene-
sis, strikingly inhibited the response to EGF and forskolin,
suggesting a role for this peptide in the regulation of cyst
formation.
This survey of potential regulators of in vitro cystogenesis
revealed interesting patterns of response. The initiation of
cystogenesis was uniquely dependent on the presence in the
medium of EGF or TGF,. Insulin was found to have a strong
supportive effect, as observed in other in vitro systems [29—311;
however, EGF and TGF, proved to be novel proponents of cyst
formation from human kidney epithelial cells in vitro as these
agents caused cysts to form in the absence of insulin. We also
found evidence that the initiation of cyst formation may be
regulated by agonists and antagonists that act in concert with
EGF and TGF. In response to several hormones, cells with
apparent functional receptors for cyclic AMP agonists formed
cysts at an increased rate if they were also provoked by EGF
(or TGF) (Figs, 4, 7). Cyclic AMP is directly mitogenic in
many cells, however, the growth-promoting effect is highly
dependent on the intracellular concentration of the compound
[321. In cysts established with EGF in vitro from human renal
cortex cells, cyclic AMP augmented cell proliferation and cyst
expansion, but alone the nucleotide was unable to initiate cysts
over a wide range of concentrations (Table I, Fig. 7). In light of
the current results, we think that cyclic AMP is a complemen-
tary factor in the initiation of cysts by EGF and TGF.
On the other hand, the initiation of cysts can be muted by
TGF,31, adenosine or modification of guanine-dependent inhib-
itory proteins (Figs. 8 to 10). Thus, cysts are dynamic structures
in vitro whose creation and growth are susceptible to regulation
by endocrine, autocrine and paracrine factors.
Once a cyst is formed in vitro, subsequent enlargement
requires at least two coordinated processes: cellular prolifera-
tion and fluid secretion. Cyclic AMP must stimulate cellular
proliferation in the presence of EGF since the combined surface
area of cysts was increased remarkably by the nucleotide, a
process that required the production of additional cells in the
cyst wall [8, 33]. Cyclic AMP agonists also had an independent
effect to stimulate the filling of cysts with fluid. This feature was
evinced most forcefully in monolayers of human renal cortex
cells that were found to secrete relatively large quantities of
fluid in the absence of EGF (Fig. 12). EGF alone had no effect
on basal fluid transport; however, the peptide enhanced the
secretory effect of a maximal concentration of forskolin. It
appears, therefore, that in vitro cystogenesis is a highly inte-
grated process in which two major signal transduction pathways
have complementary roles. A system represented by EGF and
TGF, is critically important for activating processes leading to
cellular proliferation and assembly of cells into polarized epi-
thelial structures. The adenylate cyclase system (and possibly
cyclic GMP) potentiate the proliferative actions of EGF and
TGF, but in addition, stimulate the secretion of fluid into the
cavity created by the dividing cells. EGF also appears to
"assist" in the secretion of fluid.
In vitro cystogenesis may also be limited by the disposition of
certain types of cells to secrete solutes and water in a direction
opposite to that customarily encountered in vivo. In the current
study, we observed that only cells of apparent distal nephron
origin were capable of forming cysts in collagen matrix in vitro
or establishing monolayers that secreted fluid in response to
cyclic AMP agonists. Little is known about the propensity of
differentiated renal epithelium to secrete rather than reabsorb
solutes and fluid. Proximal tubules of rabbit and human secrete
fluid in vitro in response to para-aminohippurate or human
uremic serum in the external medium [34, 35]. The secondary
active transport of relatively large organic anions promotes net
solute movement into the lumen together with the osmotic flow
of water. Fluid secretion has been observed in the proximal
tubules of lower animals, and the rate of secretion is accelerated
by increased levels of cyclic AMP [36, 371. Fluid secretion has
not been observed in intact differentiated mammalian distal
nephron segments, but monolayers of MDCK cells, which are
thought to derive from the ascending limb of Henle's loop,
distal convoluted tubule or collecting tubule, secrete fluid in
response to cyclic AMP agonists [9, 10, 12]. Further study is
needed to determine the propensity of differentiated distal
nephrons of mammalian kidneys to secrete solutes and fluid in
response to cyclic AMP agonists in the presence and absence of
EGF. One finding provides strong circumstantial evidence that
secretory mechanism will be found in distal nephrons. In a
microdissection study, Baert and Steg [3] found that the com-
mon solitary (simple) cysts that develop in human kidneys in
association with aging were derived almost exclusively from
distal tubule segments.
The same forces that drive cystogenesis in vitro may be at
work in kidneys injured by anoxia or chemical toxins. Nephron
regeneration after injury involves the proliferation or repair of
Fig. 13. Histochemical patterns in epithelia derivedfrom normal human renal Cortex. Source of cells was a frozen subeonfluent primary culture
of human kidney cortex cells. Specimens were selected for histochemical analysis to emphasize the cellular layer, and do not necessarily represent
the morphological appearance of fully distended cysts or intact monolayers. A. Cross section of a solitary cyst in Type I collagen matrix transected
near a polar margin. No reaction to PHA-E detected, 600x. B. Solitary cyst with 4+ reaction (focal) to AEI/AE3, 600x. C. Cross section of an
epithelial layer on a Transwell-col membrane. Cells show no reaction to TP, 200x. D. Cross section of cellular layer showing 4+ reaction
(generalized) to AEI/AE3, 200x.
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injured cells that repopulate the "tubular skeleton," the base-
ment membrane. When basement membranes are also dis-
rupted or destroyed in acute renal injury syndromes, orderly
nephron regeneration appears to be impaired. It is this abnor-
mal response to chemical toxins that has supported the belief
that cyst formation after feeding animals diphenylamine, di-
phenyithiazole, nordihydroguaiaretic acid, or cisplatin, may
represent altered tubular regeneration secondary to abnormal
tubule basement membrane metabolism [61.
The similarities between in vivo and in vitro cyst formation
and nephron repair are also reinforced by the observation that
parenteral EGF administration speeds functional recovery in
rats subjected to renal injury [38]. As observed in the current
study, a persistent medium level of EGF (or TGF,,) was
required for cysts to form in Type I collagen matrix. A similar
study reports that EGF or TGF is necessary for primary
cultures of baby mouse kidney cells to form tubule-like struc-
tures in a matrix composed primarily of Type IV collagen [II].
It seems reasonable to propose, therefore, that aberrant tubu-
logenesis in collagen matrices in vitro and nephron repair after
injury in vivo, may depend on mitogenic stimuli, which may
include the EGF/TGF family of growth factors.
It seems clear that epithelial cells need not be instructed by
hereditary mutation to express the cyst phenotype. The current
study offers proof that terminally differentiated cells from
normal kidneys possess sufficient information to form cysts. In
addition to the solitary or "simple cyst" there may be a
relatively newly recognized clinical counterpart to the in vitro
phenomena described in this report. The appearance of innu-
merable cysts with a propensity to form adenomas and adeno-
carcinomas in the shrunken kidneys of individuals with a wide
array of end-stage renal diseases probably reflects the final
stages of a continuum that begins with the reduction of func-
tioning nephrons [4, 5]. It is interesting to consider that the
process of replacing one kidney disease with another may
derive from a panoply of forces that are called into play to
repair and stimulate the growth of residual nephrons. It will not
be surprising to learn that peptide growth factors and hormonal
agonists with names yet unrecognized have central roles in the
pathogenesis of the acquired type of cystic kidney disease that
develops before and after the institution of dialysis therapy in
those with chronic progressive nephropathies [391.
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